Jinu earned his doctoral degree in Molecular and Cellular Biology from Ohio University in Athens, Ohio. During the course of his Ph.D, he studied the regulation of Drosophila hematopoiesis by SUMO modification under the guidance of Dr. Soichi Tanda. In the Keller laboratory, Jinu is investigating the mechanisms of resistance to receptor tyrosine-kinase inhibitors in rhabdomyosarcoma. He is also investigating the efficacy of other novel therapeutic agents for the treatment of rhabdomyosarcoma. Dr. Abraham's future goal is to become an independent scientist in the fields of Cancer Biology and Therapeutics.
